课题基金 / 基金详情

REPAIR OF MUTAGENIC 8-OXOGUANINE IN MAMMALIAN GENOMES

REPAIR OF MUTAGENIC 8-OXOGUANINE IN MAMMALIAN GENOMES
哺乳动物基因组中突变性 8-氧鸟嘌呤的修复
批准号:
2828520
负责人:
Sankar Mitra
金额:
$25.54万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-04-01 至 2002-03-31

项目摘要

项目成果

Sankar Mitra的其他基金

相似基金

相关文献

中文摘要
翻译
8-氧代鸟嘌呤(oxoguanine,G*)是最重要的致突变和致癌DNA损伤,由电离辐射(IR)和其他环境因素诱导,或由于氧化应激(通常用作细胞氧化损伤的敏感性标记)而内源性形成。 G* 具有致突变性,因为它在DNA合成过程中与A错配。 DNA中G* 的修复通过碱基切除修复(BER)途径发生,并通过G*-DNA糖基化酶(OGG)去除G * 而启动。 人类主要的OGG(hOGG-1)于1997年被克隆。 缺乏早期的证据表明OGG在人类细胞中的活性,现在似乎是由于G* 特异性结合蛋白(OGBP)的生理作用是未知的,因为是hOGG-1和最近确定的线粒体OGG之间的关系。克隆的hOGG-1从G* C中去除G*,但不从G* A对中去除G *,这与当G* 在DNA中形成时后一反应将固定突变的基本原理一致。 然而,G* 也可以从核苷酸池掺入DNA中,需要从新生链中去除以防止突变。 第二个OGG(OGG- 2),从G* A对中去除G*,与hOGG-1抗原性不同,现已在人细胞和酵母中鉴定。我们对人OGG-2的发现使我们提出了一种新的DNA中G* 修复模型。 我们的模型预测,OGG-2是新生链特异性的,并利用错配修复系统。本项目的主要目的是验证模型中的假设,并阐明OGBP在G* 抗突变过程中的可能作用。本项目的具体目标是:(1)克隆hOGG-2并制备重组OGG多肽用于结构研究;(2)验证hOGG-2与错配修复和DNA复制复合物相互作用的假设;(3)比较hOGG-1和hOGG-2底物范围和底物区分的结构基础;(4)纯化和鉴定OGBP,以阐明其生物学作用;(5)研究线粒体OGG与核OGG的关系。
英文摘要
8-oxoguanine (G*), arguably the most important mutagenic and carcinogenic DNA lesion, is induced by ionizing radiation (IR) and other environmental agents, or is formed endogenously due to oxidative stress (commonly used as the senitel marker for cellular oxidative damage). G* is mutagenic because of its mispairing with A during DNA synthesis. Repair of G* in DNA occurs via the base excision repair (BER) pathway, and is initiated with its removal by a G*-DNA glycosylase (OGG). The major human OGG (hOGG-1) was cloned in 1997. The lack of earlier evidence for OGG activity in human cells now appears to be due to a G*-specific binding protein (OGBP) whose physiological role is unknown, as is the relationship between the hOGG-1 and a recently identified mitochondrial OGG. The cloned hOGG-1 removes G* from an G* C, but not from an G* A pair, consistent with the rationale that the latter reaction will fix mutations when G* is formed in DNA. However, G* can also be incorporated into DNA from the nucleotide pool, requiring removal from the nascent strand to prevent mutation. A second OGG (OGG- 2), which removes G* from G* A pairs and is antigenically distinct from hOGG-1, has now been identified in both human cells and yeast. Our discovery of human OGG-2 has led us to propose a novel model for repair of G* in DNA. Our model predicts that OGG-2 is nascent-strand specific and utilizes the mismatch repair system. The primary objective of this project is to test the hypotheses derived from the model, and to elucidate the possible role of OGBP in the antimutagenic processing of G*. The specific aims of this project are: (1) To clone hOGG-2 and produce recombinant OGG polypeptides for collaborative structural studies; (2) to test the hypothesis that hOGG-2 interacts with mismatch repair and DNA replication complexes; (3) to compare the structural bases for the substrate range and substrate discrimination of hOGG-1 and hOGG-2; (4) to purify and characterize OGBP in order to elucidate its biological role; and (5) to investigate the relationship between the mitochondrial and nuclear OGGs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Repair of Oxidative Genome Damage Associated with Gene Activation
Repair of Oxidative Genome Damage Associated with Gene Activation
Repair of Oxidative Genome Damage Associated with Gene Activation
"Repair Co-ordination of Radiation-Induced Clustered Damage In Mammalian Genomes"
海外基金